Policy | July 28, 2025
10.18 Cr women screened for cervical cancer under Govt. schemes
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Singhal brings a powerful blend of operational excellence, investor acumen, and visionary thinking
The company has projected Rs. 5,630 crores of investment and to provide employment to 6,350 people in three phases over a period of eight years
The purpose of this investment is to meet the expenditure relating to the civil works to be undertaken for setting up of a manufacturing facility
Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
Net profit doubled to Rs. 10.8 crore, with PAT margin expanding by 560 bps to 14.3%, reflecting strong operational execution
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Sigachi Industries has reported total income of Rs. 132.18 crores during the period ended June 30, 2025
Subscribe To Our Newsletter & Stay Updated
